#RareDisease outcome assessment under #EUHTA and #JointClinicalAssessment | Becaris Publishing becarispublishing.com/digital-cont...
1
1
0
0
Hashtag
#EUHTA
Advertisement · 728 × 90
New Publication: How patients can contribute to the assessments of health technologies
📣 A new article is out in the Journal of Market Access & Health Policy as part of the Special Issue on #EUHTA.
Authored by our Treatment Access Team, it highlights why patients’ lived experience must be central throughout the EU HTA process.
👉: https://go.eurordis.org/HTAarticle
1
1
0
0
📢 Report Now Available!
CPE and @pce-europe.bsky.social hosted a webinar exploring how the new #EUHTA Regulation can help bridge the gap between policy and real-world access to innovative therapies.
📄 The full report is now available: lnkd.in/enG5RNzz
2
1
0
0
La implementación de la #EvaluaciónClínicaConjunta bajo la normativa #EUHTA plantea desafíos en el acceso a tratamientos para #enfermedades raras.
Accede al artículo completo de Félix Rubial en la revista #newsRare👇
bit.ly/4hPyLD9
0
0
0
0
Pressemitteilung zum Berliner Forum am 5.12.2025: Europäische Gesundheitsdaten und EU- Nutzenbewertung: Wie profitieren Patientinnen und Patienten? Menschen stehen in einem Raum mit einer blauen Lichtinstallation. Foto: Unsplash / note thanun
🩺 𝗘𝘂𝗿𝗼𝗽ä𝗶𝘀𝗰𝗵𝗲 𝗚𝗲𝘀𝘂𝗻𝗱𝗵𝗲𝗶𝘁𝘀𝗱𝗮𝘁𝗲𝗻 𝘂𝗻𝗱 𝗘𝗨-𝗡𝘂𝘁𝘇𝗲𝗻𝗯𝗲𝘄𝗲𝗿𝘁𝘂𝗻𝗴: 𝗪𝗶𝗲 𝗽𝗿𝗼𝗳𝗶𝘁𝗶𝗲𝗿𝗲𝗻 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝗶𝗻𝗻𝗲𝗻 𝘂𝗻𝗱 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝗲𝗻?
Aus Sicht der AWMF ist insbesondere die Qualität der Daten im EHDS entscheidend.
Zur Pressemitteilung: t1p.de/67j4f
#Gesundheitsdaten #EHDS #Europa #Medizin #Arzneimittel #EUHTA
1
0
0
0
La implementación de la #EvaluaciónClínicaConjunta bajo la normativa #EUHTA plantea desafíos en el acceso a tratamientos para #enfermedades raras.
Accede al artículo completo de Félix Rubial en la revista #newsRare👇
bit.ly/4hPyLD9
0
0
0
0
Text: View. Stakeholder Reflections on the Draft EU JCA MD Implementing Regulation
6 months from CE marking to JCA dossier submission? That’s the timeline proposed in the draft Implementing Regulation, and it’s raising alarms. Our article explores why this compressed schedule is misaligned with RWE generation for medical devices: buff.ly/tZL1r9Z #EUHTA
0
0
0
0
European Commission adopts final implementing regulation for #JointClinicalAssessments under the #EUHTA framework | Becaris Publishing becarispublishing.com/digital-cont...
1
1
0
0
Our recent white paper highlights the role of RWE in JCA guidelines and our advice for companies utilizing RWE for JCA submissions. Read our latest paper for more information at buff.ly/BB9K5nW
#JCA #EUHTA #ATMP #RWE #JCAFramework #HTA #EUHTA
0
0
0
0
Arzneimittelstudien: Konsens über klinische Studien
Die europäische Arzneimittel-Nutzenbewertung kommt. Die EMA, Zulassungsbehörden und Agenturen für Health Technology Assessment haben sich in Workshops über Probleme und Lösungen verständigt.
www.aerzteblatt.de/search/resul...
#EUHTA #JCA
1
1
0
0
Arzneimittelstudien: Konsens über klinische Studien
Die europäische Arzneimittel-Nutzenbewertung kommt. Die Europäische Arzneimittel-Agentur (#EMA), Zulassungsbehörden und Agenturen für Health Technology Assessment (HTA) haben sich in Workshops über Probleme und Lösungen verständigt.
Unser […]
0
2
0
0
Quote and potrait picture: 'Since the beginning of 2025, EU countries have been working more closely together to assess new drugs in the European health technology assessment (EU-HTA) process. The aim is to provide member states with a scientific assessment of the available evidence to inform decisions in their healthcare systems.' - Regina Skavron, Head of the Methodology and Coordination of European HTA Division, 9/2025
First EU HTAs with IQWiG involvement launched! 🚀
The Institute is involved in four #oncology drug assessments as an assessor or co-assessor.
www.iqwig.de/en/presse/pr...
#EUHTA #JCA #JointClinicalAssessment
2
1
0
0
La implementación de la #EvaluaciónClínicaConjunta bajo la normativa #EUHTA plantea desafíos en el acceso a tratamientos para #enfermedades raras.
Accede al artículo completo de Félix Rubial en la revista #newsRare👇
bit.ly/4hPyLD9
0
0
0
0
In our new white paper, we highlight the role of RWE in JCA guidelines and our advice for companies utilizing RWE for JCA submissions. Read our latest paper for more information at buff.ly/BB9K5nW
#JCA #EUHTA #ATMP #RWE #JCAFramework #HTA #EUHTA
0
0
0
0
Regina Skavron: EU-HTA in einer Minute
Die europäischen #Nutzenbewertungen, kurz #EUHTA, starten 2025. Regina Skavron, Bereichsleiterin "Methodik und Koordination der europäischen Nutzenbewertung von Arzneimitteln" im IQWiG, erklärt kurz und knapp, worum es geht.
5
3
0
0
Regina Skavron: EU-HTA in einer Minute
Die europäischen #Nutzenbewertungen (#EUHTA) starten 2025. Regina Skavron, Bereichsleiterin "Methodik und Koordination der europäischen Nutzenbewertung von Arzneimitteln" im IQWiG, erklärt kurz und knapp, worum es geht.
0
0
0
0
La implementación de la #EvaluaciónClínicaConjunta bajo la normativa #EUHTA plantea desafíos en el acceso a tratamientos para #enfermedades raras.
Accede al artículo completo de Félix Rubial en la revista #newsRare👇
bit.ly/4hPyLD9
0
0
0
0
0
0
0
0
🌐 IPOPI joined the EU Commission’s HTA Stakeholder Network, connecting with colleagues like Dr Claire Booth.
Working together for faster patient access to innovation at fair prices.
#EUHTA #HTA #HealthPolicy
2
0
0
0
La implementación de la #EvaluaciónClínicaConjunta bajo la normativa #EUHTA plantea desafíos en el acceso a tratamientos para #enfermedades raras.
Accede al artículo completo de Félix Rubial en la revista #newsRare👇
bit.ly/4hPyLD9
0
0
0
0
Our latest publication, Opportunities For and Challenges of Conducting Indirect Treatment Comparisons and Meta-Analyses for Vaccines in Post-EU HTA Regulation Era, has been featured in the Journal of Market Access and Health Policy. Read more: www.mdpi.com/2001-6689/13...
#EUHTA #HTAR #Vaccines
1
0
0
0
La implementación de la #EvaluaciónClínicaConjunta bajo la normativa #EUHTA plantea desafíos en el acceso a tratamientos para #enfermedades raras.
Accede al artículo completo de Félix Rubial en la revista #newsRare👇
bit.ly/4hPyLD9
0
0
0
0
The EU HTA journey continues…
Join Sandra Redmond from Salutem Insights tomorrow May 13th as she shares Ireland’s perspective on JCA alongside experts from Belgium, Luxemburg, Norway and Austria
🕓 16:00 | Free to attend
🔗 Register: bit.ly/3Z2iJiD
#EUHTA #HTA #MarketAccess #SalutemInsights
0
0
0
0
The EU HTA journey continues…
Join Sandra Redmond from Salutem Insights on May 13th as she shares Ireland’s perspective on JCA alongside experts from Belgium, Luxemburg, Norway and Austria
🕓 16:00 | Free to attend
🔗 Register: bit.ly/3Z2iJiD
#EUHTA #HTA #MarketAccess #SalutemInsights
0
0
0
0
The EU HTA era is here. Join Salutem Insights + EU partners for a 5-part webinar series on JCA across Europe. Starts May 6th @ 16:00.
🗓️ Sandra Redmond speaks on May 13 (Ireland focus).
🔗 Register: www.linkedin.com/feed/update/...
#EUHTA #HTA #MarketAccess #SalutemInsights
0
0
0
0
La implementación de la #EvaluaciónClínicaConjunta bajo la normativa #EUHTA plantea desafíos en el acceso a tratamientos para #enfermedades raras.
Accede al artículo completo de Félix Rubial en la revista #newsRare👇
bit.ly/4hPyLD9
0
0
0
0
La implementación de la #EvaluaciónClínicaConjunta bajo la normativa #EUHTA plantea desafíos en el acceso a tratamientos para #enfermedades raras.
Accede al artículo completo de Félix Rubial en la revista #newsRare👇
bit.ly/4hPyLD9
0
0
0
0
Teil 2 dreht sich um die Risiken von #EUHTA für #Patientinnen und #Patienten:
https://youtu.be/3Gk9lEKIwpQ?si=nnYf8-2ODzPG7-9Z
0
0
1
0
Teil 2 dreht sich um die Risiken von #EUHTA für #Patientinnen und #Patienten: youtu.be/3Gk9lEKIwpQ?...
0
0
1
0